J Strength Cond Res 2010, 24:2551–2557.PubMedCrossRef 18. Wu CL, Shih MC, Yang CC, Huang MH, Chang CK: Sodium bicarbonate supplementation prevents skilled tennis performance decline after a simulated match. J Int Soc Sports Nutr 2010, 7:33.PubMedCrossRef 19. Price MJ, Cripps D: The effects of combined glucose-electrolyte and sodium bicarbonate ingestion on prolonged intermittent exercise performance. J Sports Sci 2012, 30:975–983.PubMedCrossRef 20. Heer M, Frings-Meuthen P, Titze J, Boschmann M, Frisch S, Baecker N, Beck L: Increasing Selleck I BET 762 sodium intake from a previous low or high intake affects water, electrolyte and acid–base balance differently. Brit

J Nutr 2009, 101:1286–1294.PubMedCrossRef 21. McNaughton L: Bicarbonate ingestion: effects of dosage on 60 s cycle ergometry. J Sports Sci 1992, 10:415–423.PubMedCrossRef 22. Stephens TJ, McKenna MJ, Canny BJ, Snow RJ, McConell GK: Effect of sodium bicarbonate on muscle metabolism during intense endurance cycling. Med Sci Sports Exerc 2002, 34:614–621.PubMedCrossRef

23. Vanhatalo OSI-027 A, McNaughton LR, Siegler JH, Jones AM: Effect of induced alkalosis on the power-duration relationship for “all-out” exercise. Med Sci Sports Exerc 2010, 42:563–570.PubMed 24. Hill DW: The critical power concept. A review. Sports Med 1993, 16:237–254.CrossRef 25. Brickley G, Green S, Jenkins DG, McEinery M, Wishart C, Doust JD, Williams CA: Muscle metabolism

during constant- and alternating-intensity exercise around critical power. Int J Sports Med 2007, 28:300–305.PubMedCrossRef 26. Dill DB, Costill DL: Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 1974, Wilson disease protein 37:247–248.PubMed 27. Pietrobelli A, Formica C, Wang Z, Heymsfield SB: Dual-energy X-ray absorptiometry body composition model: review of physical concepts. Am J Physiol 1996,271(6 Pt 1):E941-E951.PubMed 28. Olsson KE, Saltin B: www.selleckchem.com/products/epoxomicin-bu-4061t.html Variation in total body water with muscle glycogen changes in man. Acta Physiol Scand 1970, 80:11–18.PubMedCrossRef 29. McNaughton L, Backx K, Palmer G, Strange N: Effects of chronic bicarbonate ingestion on the performance of high-intensity work. Eur J Appl Physiol 1999, 80:333–336.CrossRef 30. Berger NJA, McNaughton LR, Keatley S, Wilkerson DP, Jones AM: Sodium bicarbonate ingestion alters the slow but not the fast phase of V̇ O 2 kinetics. Med Sci Sports Exerc 2006, 38:1909–1917.PubMedCrossRef 31. Santalla A, Pérez M, Montilla M, Vicente L, Davison R, Earnest C, Lucia A: Sodium bicarbonate ingestion does not alter the slow component of oxygen uptake kinetics in professional cyclists. J Sports Sci 2003, 21:39–47.PubMedCrossRef 32. Burnley M, Jones AM: Oxygen uptake kinetics as a determinant of sports performance. Eur J Sports Sci 2007, 7:63–79.CrossRef 33.

CrossRefPubMed 16. Sampson BA, Misra R, Benson SA: Identification and characterization of a new gene of Escherichia coli K-12 involved in outer membrane permeability. Genetics 1989,122(3):491–501.PubMed 17. Sperandeo P, Lau FK, Carpentieri A, De Castro C, Molinaro A, Deho G, Silhavy TJ, Polissi A: Functional analysis of the protein machinery required for transport of lipopolysaccharide to the outer membrane of Escherichia coli. J Bacteriol 2008,190(13):4460–4469.CrossRefPubMed 18. Braun M, Silhavy TJ: Imp/OstA

is required for cell envelope biogenesis in Escherichia coli. Mol Microbiol 2002,45(5):1289–1302.CrossRefPubMed 19. Wu T, McCandlish AC, Gronenberg LS, Chng SS, Silhavy TJ, Kahne D: Identification of a protein complex that assembles buy Dactolisib lipopolysaccharide Y-27632 datasheet in the outer membrane of Escherichia coli. Proc Natl Acad Sci USA 2006,103(31):11754–11759.CrossRefPubMed 20. Bos MP, Tefsen B, Geurtsen J, Tommassen J: Identification of an outer membrane protein required for the transport of lipopolysaccharide to the bacterial cell surface. Proc Natl Acad Sci USA 2004,101(25):9417–9422.CrossRefPubMed 21. Karow M, Georgopoulos C: The essential Escherichia

coli msbA gene, a multicopy suppressor of null mutations in the htrB gene, is related to the universally conserved family of ATP-dependent translocators. Mol Microbiol 1993,7(1):69–79.CrossRefPubMed 22. Woebking B, Reuter G, Shilling RA, Velamakanni S, Shahi S, Venter H, Balakrishnan L, van Veen HW: Drug-lipid A interactions on the Escherichia coli ABC transporter MsbA. J Bacteriol 2005,187(18):6363–6369.CrossRefPubMed

23. Tefsen B, Bos MP, Beckers F, Tommassen J, de Cock H: MsbA is not required for phospholipid transport in Neisseria meningitidis. J Biol Chem 2005,280(43):35961–35966.CrossRefPubMed 24. Polissi A, Georgopoulos C: Mutational analysis and properties of the msbA gene of Escherichia coli, coding for an Ceramide glucosyltransferase essential ABC family transporter. Mol Microbiol 1996,20(6):1221–1233.CrossRefPubMed 25. Zhou Z, White KA, Polissi A, Georgopoulos C, Raetz CR: Function of Escherichia coli MsbA, an essential ABC family transporter, in lipid A and phospholipid biosynthesis. J Biol Chem 1998,273(20):12466–12475.CrossRefPubMed 26. Hsieh PF, Yang JC, Lin JT, Wang JT: Molecular mechanisms of clarithromycin resistance in Helicobacter pylori. J Formos Med Assoc 1998,97(7):445–452.PubMed 27. Ang S, Lee CZ, Peck K, Sindici M, Matrubutham U, Gleeson MA, Wang JT: Acid-induced gene expression in Helicobacter pylori: study in genomic scale by Bortezomib mouse microarray. Infect Immun 2001,69(3):1679–1686.CrossRefPubMed 28. Bockelmann U, Dorries HH, Ayuso-Gabella MN, Salgot de Marcay M, Tandoi V, Levantesi C, Masciopinto C, Van Houtte E, Szewzyk U, Wintgens T, et al.: Quantitative PCR monitoring of antibiotic resistance genes and bacterial pathogens in three European artificial groundwater recharge systems. Appl Environ Microbiol 2009,75(1):154–163.CrossRefPubMed 29.

aureus JCSC6943, type X SCCmec of S. aureus JCSC6945 and S. haemolyticus JCSC1435 (locus SH0098) cadD 8601-9218 Cadmium binding protein 100%, type IX SCCmec of S. aureus JCSC6943 and S. haemolyticus JCSC1435 (locus SH0099) cadX 9237-9578 Cadmium resistant BIIB057 chemical structure accessory protein 100%, type IX SCCmec of S. aureus JCSC6943 and S. haemolyticus JCSC1435 (locus SH0100) arsC 9999-9598 Arsenate reductase 100%, type IX SCCmec of S. aureus JCSC6943 and S. haemolyticus JCSC1435 (locus SH0101) arsB 11306-10017 Arsenical pump membrane protein 99%, type IX SCCmec of S. aureus JCSC6943 and S. haemolyticus JCSC1435 (locus SH0102) arsR 11623-11302

Arsenical resistance operon repressor 100%, type IX SCCmec of S. aureus JCSC6943, type X SCCmec of S. aureus JCSC6945 and S. haemolyticus JCSC1435 (locus SH0103) IS431 11697-12486 IS431   mecRΔ 12503-12487 Signal transducer protein   mecA 12603-14609 Penicillin binding protein 2a   orf19 KU55933 mw 15083-14655 Hypothetical protein   maoC 15923-15180 Putative acyl dehydratase maoc   orf21 17208-16840 Putative HMG-CoA synthase (partial)   IS431 17209-17998 IS431  

copA 18241-20262 Copper-transporting atpase 99%, type X SCCmec of S. aureus JCSC6945. orf24 20277-21710 Putative multicopper oxidases 99%, S. haemolyticus JCSC1435 (locus SH0106) lip 21730-22212 Lipoprotein 99%, S. aureus JCSC6943 acf 22588-23073 Putative Acyl-CoA acyltransferase 97%, S. haemolyticus JCSC1435 (locus SH0117) hsdR 23254-23667 Type I restriction endonuclease, HsdR 97%, S. haemolyticus JCSC1435(locus SH0118) putP 25274-23736 Sodium/proline symporter (High affinity proline permease) 78%, S. saprophyticus ATCC 15305 selleck chemical (locus SSP0399) IS431Δ 26462-27184 IS431, truncated Vorinostat   FAD 27261-28382 FAD-dependent pyridine nucleotide-disulphide oxidoreductase 66%, a few S. aureus strains, e.g. COL feoB 28376-29272 FeoB family ferrous iron transporter 68% (partially, from position 28804 to 29216), S. carnosus TM300

orf31 29337-29717 Putative transmembrane protein 73% (partially, from position 29438 to 29618), S. aureus MSHR1132 IS431Δe 30690-29891 IS431, incomplete due to internal termination   orf32 31660-33822 ABC-type bacteriocin transporter family protein 71%, S. epidermidis plasmid SAP105A orf33 34541-35809 DUF867 type protein, putative phage-related protein 71% (partially from position 35252), S. epidermidis ATCC 12228 ISSha1 37543-36061 ISSha1 98%, S. haemolyticus JCSC1435 chr 38832-37669 Chromate transporter 66% (partially from position 37895 to 38782), Oceanobacillus iheyensis HTE831 arsC 39261-38869 Arsenate reductase 97%, S. aureus strains LGA251 and M10/0061 arsB 40577-39279 Arsenical pump membrane protein 92%, S. xylosus plasmid pSX267 arsR 40885-40571 Arsenical resistance operon repressor 91%, S. aureus plasmid SAP099B and EDINA orf39 41223-41771 DUF576 type protein 100%, S. haemolyticus JCSC1435 (locus SH0120) orf40 41768-41935 Hypothetical protein 100%, S.